The carrier screening global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Carrier Screening Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The carrier screening market size has grown rapidly in recent years. It will grow from $2.31 billion in 2023 to $2.7 billion in 2024 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to increasing genetic disorders awareness, rising maternal age, family planning and pregnancy awareness, prevention of genetic diseases, public health initiatives, increased focus on inherited conditions.
The carrier screening market size is expected to see rapid growth in the next few years. It will grow to $4.91 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The growth in the forecast period can be attributed to precision medicine advancements, expanded panel offerings, consumer genomics and direct-to-consumer testing, focus on rare and ultra-rare diseases, government and insurance support, pharmacogenomics integration. Major trends in the forecast period include advancements in genetic technologies, integration with prenatal testing, rise in personalized medicine, counseling and education services, ethical and legal considerations.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report
Scope Of Carrier Screening Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Carrier Screening Market Overview
Market Drivers –
An increase in fetal chromosomal abnormalities and genetic disorders is expected to propel the growth of the carrier screening market going forward. Fetal chromosomal abnormalities refer to a fetus with an abnormal number of chromosomes, an abnormal quantity of DNA inside a chromosome. Prenatal testing for chromosomal abnormalities is intended to provide an accurate assessment of a patient’s risk of carrying a fetus with a chromosomal disorder. For instance, in February 2022, according to estimates by the World Health Organization, a Switzerland-based global health agency, birth defects cause 240 000 newborns to pass away in the first 28 days of life each year. An additional 170,000 children between the ages of 1 month and 5 years die as a result of birth defects. Moreover, in March 2022, according to an article published by the Government of United Nations, Down syndrome is estimated to affect 1 in 1,000 to 1 in 1,100 live births worldwide. Every year, between 3,000 and 5,000 children are born with this chromosome disorder. Therefore, an increase in fetal chromosomal abnormalities and genetic disorders is driving the growth of the carrier screening market.
Market Trends –
Major companies operating in the carrier screening market are focusing on product developments, such as screening tests family, to sustain their position in the market. Screening tests are medical procedures or tests performed on individuals who do not exhibit any symptoms of a particular disease or condition. For instance, in June 2023, Blueprint Genetics, a Finland-based company specializing in genetic testing and diagnostics, introduced a new offering called the Screening Tests family. This product is designed for specific purposes such as pregnancy, family planning, and comprehensive health checks for asymptomatic individuals. The objective is to identify any heightened risks, empowering individuals to make informed decisions regarding family planning and health. Blueprint Genetics aims to offer actionable information that enables proactive choices based on the available options, emphasizing a commitment to supporting individuals in making informed decisions about their future well-being.
The carrier screening market covered in this report is segmented –
1) By Type: Expanded Carrier Screening, Targeted Disease Carrier Screening
2) By Medical Condition: Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Other Medical Conditions
3) By Technology: DNA Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies
4) By End User: Hospitals, Reference Laboratories, Physician Offices and Clinics, Other End Users
Get an inside scoop of the carrier screening market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7952&type=smp
Regional Insights –
North America was the largest region in the carrier screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the carrier screening market report during the forecast period. The regions covered in the carrier screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the carrier screening market report are Invitae Corporation, BGI Genomics Co. Ltd., Centogene NV, Eurofins Scientific SE, Fulgent Genetics Inc., Genealogy by Genetics Ltd., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, MedGenome Inc., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 Holdings Corporation, Thermo Fisher Scientific Inc., 23andMe Holding Co., REALM IDx Inc., Associated Regional and University Pathologists Inc., Genedx LLC, Genomic Health Inc., GenPath Consultants And Technologies Private Limited, Good Start Genetics Inc., NIPD Genetics Co. Pvt. Ltd., OraSure Technologies Inc., Pathway Genomics Corp., PerkinElmer Inc., PreventionGenetics LLC, Progenity Inc.
1. Executive Summary
2. Carrier Screening Market Report Structure
3. Carrier Screening Market Trends And Strategies
4. Carrier Screening Market – Macro Economic Scenario
5. Carrier Screening Market Size And Growth
…..
27. Carrier Screening Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
